Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]
H. Ludwig(Universitätsmedizin Göttingen), Heidemarie Huber, DM Nachbaur, Michael Krainer(Medical University of Vienna), E. Fritz(Unknown)
Cited by 142
Related Papers
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450
Inspiration Is the Major Regulator of Human CSF Flow
|Journal of Neuroscience|2015|413
Germ-Line<i>BRCA1</i>Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
|New England Journal of Medicine|1996|388
Jewish gynecologists in Germany in the first half of the twentieth century
|Archives of Gynecology and Obstetrics|2005|379